Literature DB >> 2874485

Barrett's esophagus.

S J Spechler, R K Goyal.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 2874485     DOI: 10.1056/NEJM198608073150605

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  155 in total

1.  Cytochromes P450 are expressed in proliferating cells in Barrett's metaplasia.

Authors:  S J Hughes; M A Morse; C M Weghorst; H Kim; P B Watkins; F P Guengerich; M B Orringer; D G Beer
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

2.  Preoperative chemotherapy unmasks underlying Barrett's mucosa in patients with adenocarcinoma of the distal esophagus.

Authors:  J Theisen; H J Stein; H J Dittler; M Feith; C Moebius; W K H Kauer; M Werner; J R Siewert
Journal:  Surg Endosc       Date:  2002-01-09       Impact factor: 4.584

3.  The phenotype of gastric mucosa coexisting with Barrett's oesophagus.

Authors:  M Rugge; V Russo; G Busatto; R M Genta; F Di Mario; F Farinati; D Y Graham
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

Review 4.  Endoscopic ablation of Barrett's esophagus.

Authors:  M B Fennerty
Journal:  Curr Gastroenterol Rep       Date:  1999-06

5.  Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma.

Authors:  J W van Sandick; J J van Lanschot; B W Kuiken; G N Tytgat; G J Offerhaus; H Obertop
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

6.  Time gated fluorescence spectroscopy in Barrett's oesophagus.

Authors:  M-A E J Ortner; B Ebert; E Hein; K Zumbusch; D Nolte; U Sukowski; J Weber-Eibel; B Fleige; M Dietel; M Stolte; G Oberhuber; R Porschen; B Klump; H Hörtnagl; H Lochs; H Rinneberg
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 7.  Report of an Amsterdam working group on Barrett esophagus.

Authors:  G J A Offerhaus; P Correa; S van Eeden; K Geboes; P Drillenburg; M Vieth; M L van Velthuysen; H Watanabe; P Sipponen; F J W ten Kate; F T Bosman; A Bosma; A Ristimaki; H van Dekken; R Riddell; G N J Tytgat
Journal:  Virchows Arch       Date:  2003-09-27       Impact factor: 4.064

8.  Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions--a debate: pro.

Authors:  Tomás Navarro-Rodriguez; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

9.  Role of bile acids, prostaglandins and COX inhibitors in chronic esophagitis in a mouse model.

Authors:  C Poplawski; D Sosnowski; A Szaflarska-Popławska; J Sarosiek; R McCallum; Z Bartuzi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

10.  Etiology, treatment, and outcome of esophageal ulcers: a 10-year experience in an urban emergency hospital.

Authors:  Daisuke Higuchi; Choichi Sugawa; Sachin H Shah; Satoshi Tokioka; Charles E Lucas
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.